Horizons’ mindset is centered on listening, innovating and creating to save lives. In doing so, we design and develop minimally invasive navigated and non-navigated devices.
These instruments aid interventional medical practitioners to diagnose malignant growths in an accurate and timely manner. Our devices enable the detection and diagnosis of pulmonary and gastrointestinal cancers, in pursuit of rapid treatment.
Horizons International Corp. (HIC) is committed to designing medical devices that advance the capture of cells and tissues needed to identify gastrointestinal diseases and cancerous growths at all stages.
HIC is a global business with direct commercial operations, partners and distributors around the world. We are seeking new business partners in other specialties interested in developing product extensions from our existing devices or sharing intellectual property on behalf of a product extension.
Horizons’ regulatory certifications and approvals are geographically expansive and up to date. This enables the approval and registration process, to market our products in new geographies and to secure appropriate reimbursements. Our products are differentiated to enhance our customer offering.
HIC works in collaboration with its customers, physicians and key opinion leaders (KOLs). All New Product development needs and opportunities are vetted through our funnel process to further improve our existing product line and fulfill new unmet needs. Customer feedback and integration is at the core of our continuous product innovation.
